Effects of L-Dopa and STN-HFS Dyskinesiogenic Treatments on NR2B Regulation in Basal Ganglia in the Rat Model of Parkinson's Disease

Neurobiology of Disease - United States
doi 10.1016/j.nbd.2012.06.009
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Elsevier BV

Related search

The Effects of Cues on Neurons in the Basal Ganglia in Parkinson's Disease

Frontiers in Integrative Neuroscience
Molecular NeuroscienceSensory SystemsCellularCognitive Neuroscience
2012English

Illuminating Basal Ganglia and Beyond in Parkinson's Disease

Movement Disorders
Neurology
2018English

Levodopa Effect on Basal Ganglia Motor Circuit in Parkinson's Disease

CNS Neuroscience and Therapeutics
PsychiatryMental HealthPhysiologyPharmacology
2016English

Oscillatory Activity in Basal Ganglia and Motor Cortex in an Awake Behaving Rodent Model of Parkinson's Disease

Basal Ganglia
Neurology
2014English

Differential Involvement of D1 and D2 Dopamine Receptors in L-Dopa-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2009English

Identifying the Basal Ganglia Network Model Markers for Medication-Induced Impulsivity in Parkinson's Disease Patients

PLoS ONE
Multidisciplinary
2015English

Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-Dopa-Induced Dyskinesia in Rat Model of Parkinson's Disease

PLoS ONE
Multidisciplinary
2011English

Noradrenaline Neuron Degeneration Contributes to Motor Impairments and Development of L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease

Experimental Neurology
Developmental NeuroscienceNeurology
2014English

Goal-Directed and Habitual Control in the Basal Ganglia: Implications for Parkinson's Disease

Nature Reviews Neuroscience
Neuroscience
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy